DCOY — DECOY THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $535,059 | — | -$7.2M | — | -158.2% | — | -971.9% | — | — | — | — |
Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -11.34 | — | -11.34 | -11.34 | 1 | −1 |
| Dec 2027 | -9.46 | — | -9.46 | -9.46 | 1 | −1 |
| Dec 2028 | -16.49 | — | -16.49 | -16.49 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 6 SEC-registered investment managers reported holding DCOY (DECOY THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $87.65K across 44.48K shares. That is +184.9% by share count (+7.98K shares) versus the previous quarter, while reported value moved -21.9%. Ownership is concentrated: the five largest holders account for 99.8% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 2 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of DECOY THERAPEUTICS INC (DCOY) include COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., ranked by reported 13F value among the 17 institutional holders on this page.
DCOY is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 6 | 44.48K | $87.65K | +184.9% |
| Q2 2026 | 4 | 4.32K | $31.04K | -82.1% |
| Q1 2026 | 4 | 1.61K | $10.51K | -83.2% |
| Q4 2025 | 9 | 79.25K | $51.43K | +13300.0% |
| Q3 2025 | 5 | 537 | $1.98K | — |
| Q3 2023 | 1 | 1.80K | $6.00K | — |
Over the 6 quarters shown, institutional share counts increased 2371% in aggregate (Q3 2023 → Q3 2026); the largest single-quarter swing was Q4 2025 (+13300.0%).
Top Institutional Holders (Q3 2026) — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 32.00K | $63.04K | 0.00% | New | |
| 4.53K | $8.91K | 0.00% | Add | |
| 4.03K | $7.95K | 0.00% | Hold | |
| 3.73K | $7.36K | 0.00% | Add | |
| 111 | $219 | 0.00% | New | |
| 80 | $170 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 4.03K | $29.00K | 0.00% | New | |
| 256 | $1.84K | 0.00% | Reduce | |
| 25 | $180 | 0.00% | Reduce | |
| 2 | $14 | 0.00% | New |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.02K | $6.67K | 0.00% | Reduce | |
| 546 | $3.57K | 0.00% | Reduce | |
| 41 | $268 | 0.00% | New | |
| 1 | $7 | 0.00% | New |
Q4 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 28.00K | $18.18K | 0.00% | New | |
| 19.99K | $12.97K | 0.00% | New | |
| 10.94K | $7.10K | 0.00% | New | |
| 10.92K | $7.08K | 0.00% | New | |
| 4.92K | $3.19K | 0.00% | Add | |
| 4.44K | $2.88K | 0.00% | New | |
| 36 | $23 | 0.00% | Add | |
| 1 | $1 | 0.00% | Hold | |
| 3 | $1 | 0.00% | Hold |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 500 | $1.83K | 0.00% | New | |
| 29 | $106 | 0.00% | New | |
| 3 | $17 | 0.00% | New | |
| 4 | $15 | 0.00% | New | |
| 1 | $4 | 0.00% | New |
Q3 2023 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.80K | $6.00K | 0.00% | New |
New Positions (Q3 2026)
- COMMONWEALTH EQUITY SERVICES, LLC 32.00K sh · $63.04K
- SBI Securities Co., Ltd. 111 sh · $219
- JPMorgan Chase & Co 80 sh · $170
Fully Exited (vs previous quarter)
- Caitong International Asset Management Co., Ltd sold 2 sh · $14
Fund Position History — shares by quarter (top 17 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q3 2023 |
|---|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | 32.00K | — | — | — | — | — |
| UBS Group AG | 4.53K | 25 | 546 | 4.92K | 29 | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.03K | 4.03K | — | — | — | — |
| Tower Research Capital LLC (TRC) | 3.73K | 256 | 1.02K | 4.44K | — | — |
| SBI Securities Co., Ltd. | 111 | — | — | — | — | — |
| JPMorgan Chase & Co | 80 | — | — | — | — | — |
| Warberg Asset Management LLC | — | — | — | 28.00K | — | — |
| StoneX Group Inc. | — | — | — | 19.99K | — | — |
| XTX Topco Ltd | — | — | — | 10.94K | — | — |
| Geode Capital Management | — | — | — | 10.92K | — | — |
| SIMPLEX TRADING, LLC | — | — | — | — | — | 1.80K |
| Advisory Services Network, LLC | — | — | 41 | — | 500 | — |
| Bank of America Corp | — | — | — | 36 | 4 | — |
| OSAIC HOLDINGS, INC. | — | — | — | 3 | 3 | — |
| Caitong International Asset Management Co., Ltd | — | 2 | — | — | — | — |
| Morgan Stanley | — | — | 1 | — | — | — |
| DANSKE BANK A/S | — | — | — | 1 | 1 | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold DCOY?
As of 2026-Q3, 6 institutional funds reported holding DCOY (DECOY THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $87.65K.
How many shares of DCOY do institutions own?
13F filers reported 44.48K shares of DCOY, worth $87.65K in aggregate at the end of 2026-Q3.
Is institutional ownership of DCOY rising or falling?
Share counts moved +184.9% versus the prior quarter — accumulation.
Who are the top institutional holders of DCOY?
The largest 13F holders are COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of DECOY THERAPEUTICS INC?
The major shareholders of DECOY THERAPEUTICS INC (DCOY) by reported 13F value are COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, StoneX Group Inc., UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC, among 17 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.